Division of Internal Medicine,Hepatobiliary and Immunoallergic Diseases,IRCCS Azienda Ospedaliero-Universitaria di Bologna,University of Bologna,Bologna 40138,Italy;
Center for the Study and Treatment of Autoimmune Diseases of the Liver and Biliary System,Department of Medical and Surgical Sciences,University of Bologna,Bologna 40138,Italy;
Division of Internal Medicine and Immunorheumatology,IRCCS Azienda Ospedaliero-Universitaria di Bologna,Center for the Study and Treatment of Autoimmune Diseases of the Liver and Biliary System,University of Bologna,Bologna 40138,Italy;
Department of Medical and Surgical Sciences,University of Bologna,Bologna 40138,Italy;
Division of Internal Medicine,IRCCS Azienda Ospedaliero-Universitaria di Bologna,Center for the Study and Treatment of Autoimmune Diseases of the Liver and Biliary System,Bologna 40138,Italy;
Division of Internal Medicine,Morgagni-Pierantoni Hospital,Forlì47100,Italy;
Department of Science for the Quality of Life,University of Bologna,Bologna 40138,Italy;
Autoimmune liver disease; Hepatitis B virus-related chronic hepatitis; Hepatitis C virus-related chronic hepatitis; Hepatocellular carcinoma; Tumor microenvironment;